Advancing Breast Cancer Research: Lambda & Novum's Commitment to Patient-Centric Trials Advancing Breast Cancer Research – Lambda and Novum’s Commitment to Patient-Centric Trials Post author:Dipesh Chodvadia Post published:November 30, 2023 Post category:Case-Study Tags: Case-Study, Oncology Read more articles Previous PostAdvancing Pediatric Clinical Trials – Overcoming Challenges in the Clinical Trial of Pegfilgrastim Next PostAccelerating Patient Recruitment in Ranibizumab Study for Retinopathy of Prematurity in Preterm Infants You Might Also Like Insights – Administering Iron Sucrose IV Injection through Infusion Pump to over 150 Healthy Participants November 30, 2023 Overcoming challenges in a Patient-based PK study (Paliperidone) held during the COVID-19 pandemic November 30, 2023 From Study Execution to EMA Success A Global Phase III Program for Ranibizumab – Ophthalmic Biosimilar June 9, 2026
Insights – Administering Iron Sucrose IV Injection through Infusion Pump to over 150 Healthy Participants November 30, 2023
Overcoming challenges in a Patient-based PK study (Paliperidone) held during the COVID-19 pandemic November 30, 2023
From Study Execution to EMA Success A Global Phase III Program for Ranibizumab – Ophthalmic Biosimilar June 9, 2026